GSK to acquire Sierra Oncology for US $1.9bn
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
Momelotinib complements GSK’s existing expertise in haematology, with Sierra Oncology anticipating US regulatory submission in Q2 this year and EU submission in the second half of 2022
The initial courses of Lap. Hernia Masterclass will encompass commonly performed hernia procedures
The Centre aims to channel the potential of traditional medicine by integrating it with technological advancements and evidence-based research
The minister exhorted the pharmaceutical sector to prepare a plan for the next 25 years
Turn has developed a novel cell rejuvenating platform with significant potential for application in an array of age-related diseases
The investment of around €7 million significantly enhances the site’s flexibility and capacity in synthesizing modern, complex and even corrosive molecules
This could be a game-changer for the prevention of the disease; seeing more doses of the life-saving jab reach more girls
Pharmapack trends are a key barometer of global device and packing opportunities in 2022
It supports advanced research and helps scientists accelerate potential cures, drug discoveries and diagnostics research
Crosscope Dx is a workflow integrated vendor-agnostic digital pathology platform that offers end-to-end digital pathology solutions with advanced workflow features
Subscribe To Our Newsletter & Stay Updated